Low-dose intravitreal cidofovir (HPMPC) therapy of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome

  • Taskintuna, I
  • Rahhal, F M
  • Arevalo, J F
  • Munguia, D
  • Banker, A S
  • De Clercq, Erik
  • Freeman, W R
Publication date
June 1997
Publisher
Elsevier Science
ISSN
0161-6420
Journal
issn:0161-6420

Abstract

The authors have shown that long-term treatment of cytomegalovirus (CMV) retinitis with 20-microgram intravitreal injections of cidofovir (HPMPC) is highly effective but may be associated with iritis and profound hypotony. They evaluated the efficacy and safety of 10-microgram intravitreal injections of cidofovir and made comparisons with their findings of 20-microgram injections.status: publishe

Extracted data

We use cookies to provide a better user experience.